NCT00397332View on ClinicalTrials.gov

Alefacept for Chronic Graft Versus Host Disease

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

January 31, 2013

Study Completion Date

July 31, 2013

Conditions
Resistant Chronic GVHD
Interventions
DRUG

Alefacept

IM Alefacept

Trial Locations (1)

91120

Department of Stem cell Transplantation & Cancer immunotherapy; Cell Therapy & Transplantation Biology Research Laboratory, Hadassah University Hospital, Jerusalem

All Listed Sponsors
lead

Hadassah Medical Organization

OTHER

NCT00397332 - Alefacept for Chronic Graft Versus Host Disease | Biotech Hunter | Biotech Hunter